Monopar Therapeutics Inc.

NASDAQ: MNPR · Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT

Monopar Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
39.5B 39.71M 45.82M 6.02M 6.12M 7.81M 7.27M 5.52M 7.21M 5.73M 8.19M 14.32M 16.46M 17.82M 20.3M 22.34M 24.29M 25.72M
Short-Term Investments
n/a 14.84M 14.4M n/a 998.84K 985.73K n/a 2.98M 2.98M 5.95M 4.93M n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a -0.00 0.00 0.00 n/a -0.00 n/a n/a 68.86K 68.86K 68.86K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
14.25B 523.56K 78.87K 49.57K 61.02K 118.99K n/a 73.19K 109.87K 106.82K 45.98K 55.7K 189.18K 193.63K 217.75K 106.8K 95.56K 114.57K
Total Current Assets
53.75B 55.08M 60.29M 6.07M 7.18M 8.91M 7.33M 8.57M 10.3M 11.78M 13.17M 14.37M 16.65M 18.01M 20.52M 22.45M 24.39M 25.84M
Property-Plant & Equipment
118.17M 9.1K n/a n/a n/a n/a 12.65K 25.09K 37.33K 49.38K 61.23K 72.89K 84.36K 53.69K n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
118.17M 9.1K n/a n/a n/a n/a 12.65K 25.09K 37.33K 49.38K 61.23K 72.89K 84.36K 53.69K n/a 68.86K 68.86K 68.86K
Total Assets
53.87B 55.09M 60.29M 6.07M 7.18M 8.91M 7.35M 8.59M 10.34M 11.83M 13.23M 14.45M 16.74M 18.07M 20.52M 22.52M 24.46M 25.91M
Account Payables
n/a 1.49M 2.25M 1.12M 1.09M 1.44M 1.76M 1.98M 2.5M 2.89M 3.13M 1.91M 2.19M 1.07M 1.58M 1.24M 1.1M 806.27K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
1.58B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
1.58B 1.49M 5.25M 1.12M 1.09M 1.44M 1.76M 1.98M 2.5M 2.89M 3.13M 1.91M 2.19M 1.07M 1.58M 1.24M 1.1M 806.27K
Long-Term Debt
80.37M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
80.37M n/a n/a n/a n/a n/a n/a n/a n/a 2.89M 8.41K 20.85K 33.09K 25.34K n/a n/a n/a n/a
Total Liabilities
1.66B 1.49M 5.25M 1.12M 1.09M 1.44M 1.76M 1.98M 2.5M 2.89M 3.14M 1.94M 2.22M 1.1M 1.58M 1.24M 1.1M 806.27K
Total Debt
80.37M n/a n/a n/a n/a n/a n/a n/a n/a n/a 8.41K 20.85K 33.09K 25.34K n/a n/a n/a n/a
Common Stock
6.13M 6.12K 6.1K 3.52M 17.6K 17.48K 14.9K 14.2K 13.9K 13.22K 12.95K 12.86K 12.7K 12.62K 12.6K 12.59K 12.58K 12.57K
Retained Earnings
-80.87B -78.42M -75.79M -64.87M -63.56M -61.85M -60.21M -58.39M -56.44M -54.24M -51.8M -48.91M -46.51M -43.75M -41.29M -38.61M -36.15M -34.07M
Comprehensive Income
77.58M -21.78K 35.99K -10.99K 8.26K 4.23K -14.13K 3.95K 7.22K 31.79K 8.94K 42.98K 17.47K -3.74K -3.16K -5.15K -5.16K -5.1K
Shareholders Equity
52.2B 53.59M 55.04M 4.95M 6.09M 7.48M 5.59M 6.61M 7.84M 8.94M 10.09M 12.51M 14.52M 16.97M 18.94M 21.28M 23.35M 25.1M
Total Investments
n/a 14.84M 14.4M 6.01B 998.84K 985.73K n/a 2.98M 2.98M 5.95M 4.93M n/a n/a n/a n/a n/a n/a n/a